ANDAORALCAPSULE
Approved
Sep 1994
Lifecycle
Post-LOE
Competitive Pressure
60/100
Clinical Trials
20
Mechanism of Action
[see Microbiology ()].
Indications (6)
infections due to susceptible strains of designated microorganismsthe treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus speciesthe treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coliProteus mirabilisEnterococcus faecalisthe treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus spp
Clinical Trials (5)
A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin
Started Nov 2025
12 enrolled
Drug InteractionGERD (Gastroesophageal Reflux Disease)Safety, and Tolerability
Oral Sulopenem Versus Amoxicillin/Clavulanate for Uncomplicated Urinary Tract Infection in Adult Women
Started Oct 2022
Study to Compare the Efficacy of Pristinamycin (Pyostacine ®) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia
Started Apr 2015
161 enrolled
Pneumonia
Study to Assess the Efficacy and Safety of Potassium Clavulanate/Amoxicillin in Children With Acute Bacterial Rhinosinusitis
Started Aug 2013
27 enrolled
Sinusitis, Acute
A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate
Started Jan 2013
0Diarrhoea